JP Stock MarketDetailed Quotes

4574 Taiko Pharmaceutical

Watchlist
  • 415
  • +10+2.47%
20min DelayMarket Closed Aug 9 15:00 JST
21.01BMarket Cap-5442P/E (Static)

Taiko Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Taiko Pharmaceutical Earnings Date

Currency: JPY

Period

H1 FY2024 Earnings

Aug 9, 2024

Revenue(YoY)

2.86B

+14.95%
NI to Common Holders(YoY)

764.00M

+248.64%
Analyst Rating

No Data

Taiko Pharmaceutical Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 0 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: JPY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
May 10, 20242024/Q11.377B / ----
Nov 10, 20232023/Q31.929B / ----
May 12, 20232023/Q11.167B / ----
Nov 11, 20222022/Q31.532B / ----
Aug 12, 20222022/Q21.236B / 1.200B--
DatePeriodRevenue/EstimateEarnings Call
May 10, 20242024/Q11.377B / ----
Nov 10, 20232023/Q31.929B / ----
May 12, 20232023/Q11.167B / ----
Nov 11, 20222022/Q31.532B / ----
Aug 12, 20222022/Q21.236B / 1.200B--

Unlock Free Earnings Estimates

Taiko Pharmaceutical Earnings Reports

  • Taiko Pharmaceutical: Confirmatory letter.

    Aug 9 02:34 ET

  • Taiko Pharmaceutical: Half Year Report - Term 79 (2024/01/01 - 2024/06/30)

    Aug 9 02:33 ET

  • Taiko Pharmaceutical: Announcements of individual stocks regarding the revision of consolidated performance estimates and the restructuring of production system in pharmaceutical business (recognition of impairment losses).

    Aug 9 02:30 ET

  • Taiko Pharmaceutical: 2024 December Q2 (Interim) Financial Results (Japan Standard) (Consolidated)

    Aug 9 02:30 ET

    • Read more

    Analysis

    Analyst Rating

    No Data

    Price Target

    No Data

    Heat List
    JP
    Overall
    Symbol
    Latest Price
    % Chg